中電興發(002298.SZ):股東束龍勝減持比例變動達1.03%
格隆匯5月30日丨中電興發(002298.SZ)公佈,公司於2024年5月30日接到公司持股5%以上股東束龍勝的通知:束龍勝先生因個人債務且已收到法院強制執行通知書,為了避免其股份被強制執行給投資者特別是中小投資者、公司和個人等各方面帶來不必要的損失或造成不良影響,自2023年10月10日至2024年5月30日通過大宗交易和集中競價方式合計減持其持有公司7,601,726股股份,佔公司總股本的1.03%,其中通過集中競價合計減持股份3,604,045股股份,佔公司總股本的0.49%,且非窗口期,符合相關規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.